Poolbeg Pharma on JPM 2026: Key Takeaways from Healthcare’s Premier Investment Event
Episode 2287 · Jan 21, 08:00 AM
Share
Subscribe
Following attendance at the J.P. Morgan Healthcare Conference in San Francisco, Jeremy Skillington, CEO of Poolbeg Pharma discusses the key themes shaping global healthcare in 2026 — from cancer immunotherapy and GLP-1 therapies to deal appetite and strategic partnerships — and what these insights mean for Poolbeg’s strategy in the year ahead.